CSIMarket
 

Inovio Pharmaceuticals Inc   (NASDAQ: INO)

Inovio Pharmaceuticals Inc 's

Competitiveness




 

INO Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Inovio Pharmaceuticals Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 7.97 %, recorded in the same quarter.

List of INO Competitors





Revenue Growth Comparisons




Net Income Comparison


Inovio Pharmaceuticals Inc , slower than the average decrease reported by the company's competitors of -44.67 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -44.67 %

<<  INO Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Inovio Pharmaceuticals Inc




Vaxart Inc
Share Performance



+29.34%
One Year



Vaxart Inc
Profile

Vaxart Inc's business model involves the development of oral vaccines through their proprietary tablet vaccine delivery platform.

More about Vaxart Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 119.024 mill. $ 243.064 mill. $ 38.589 mill.


Precigen Inc
Share Performance



+60.28%
This Year



Precigen Inc
Profile

Precigen Inc is a biotechnology company that focuses on the development and commercialization of innovative genetic therapies. Their business model revolves around leveraging their proprietary technologies and expertise in gene editing and synthetic biology to create transformative medical solutions. With a strong emphasis on research and development, Precigen aims to bring cutting-edge genetic therapies to market and address critical unmet medical needs.

More about Precigen Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,430.436 mill. $ 31.595 mill. $ -204.418 mill.


Pfizer Inc
Share Performance



+9.05%
This Quarter



Pfizer Inc
Profile

Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.

More about Pfizer Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 162,706.450 mill. $ 63,696.000 mill. $ 4,370.000 mill.


Oragenics Inc
Share Performance



-40.96%
This Year



Oragenics Inc
Profile

Oragenics Inc's business model revolves around developing and commercializing novel technologies and products to address unmet healthcare needs.

More about Oragenics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.133 mill. $ - mill. $ -9.827 mill.


Novartis Ag
Share Performance



+16.39%
This Year



Novartis Ag
Profile

Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.

More about Novartis Ag's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 315,243.750 mill. $ 56,674.000 mill. $ 17,991.000 mill.

27 more competitors available

Sign in to see all competitors

Sources: Inovio Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Inovio Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.